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Abstract: Obtaining differentiated cells with high physiological functions by an efficient, but simple
and rapid differentiation method is crucial for modeling neuronal diseases in vitro using human
pluripotent stem cells (hPSCs). Currently, methods involving the transient expression of one
or a couple of transcription factors have been established as techniques for inducing neuronal
differentiation in a rapid, single step. It has also been reported that microRNAs can function as
reprogramming effectors for directly reprogramming human dermal fibroblasts to neurons. In this
study, we tested the effect of adding neuronal microRNAs, miRNA-9/9*, and miR-124 (miR-9/9*-124),
for the neuronal induction method of hPSCs using Tet-On-driven expression of the Neurogenin2 gene
(Ngn2), a proneural factor. While it has been established that Ngn2 can facilitate differentiation from
pluripotent stem cells into neurons with high purity due to its neurogenic effect, a long or indefinite
time is required for neuronal maturation with Ngn2 misexpression alone. With the present method,
the cells maintained a high neuronal differentiation rate while exhibiting increased gene expression
of neuronal maturation markers, spontaneous calcium oscillation, and high electrical activity with
network bursts as assessed by a multipoint electrode system. Moreover, when applying this method
to iPSCs from Alzheimer’s disease (AD) patients with presenilin-1 (PS1) or presenilin-2 (PS2) mutations,
cellular phenotypes such as increased amount of extracellular secretion of amyloid β42, abnormal
oxygen consumption, and increased reactive oxygen species in the cells were observed in a shorter
culture period than those previously reported. Therefore, it is strongly anticipated that the induction
method combining Ngn2 and miR-9/9*-124 will enable more rapid and simple screening for various
types of neuronal disease phenotypes and promote drug discovery.
Keywords: human pluripotent stem cell; excitatory neuron; neurogenin2; microRNA-9/9*;
microRNA-124; Alzheimer’s disease; presenilin1; presenilin2

1. Introduction
Utilization of human pluripotent stem cells has become important for recapturing human
development and for disease analysis that would provide a basis for regenerative medicine and drug
discovery. In particular, the discovery of human induced-pluripotent stem cells (iPSCs) [1] enabled
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researchers to overcome the issue of direct inaccessibility to the human brain, which has been a major
barrier in patient cell-based research. It is not an overstatement to say that analysis and cell therapy using
neural cells differentiated from patient-derived iPS cells has increasingly become more attainable [2,3].
Meanwhile, some technical problems concerning neuronal induction still remain. First, it is necessary to
increase the purity of the target neurons. Methods for inducing neural differentiation through embryoid
body’s (EB’s) and neural stem cells using various physiological substances or activators/inhibitors
of cellular signaling have been investigated. A previous report introduced a method that promotes
neuronal differentiation through dual SMAD signal inhibition, which was proven to be very effective [4].
Subsequently, culture methods targeting various types of neuronal cells have been developed and are
useful to some extent for analyzing the pathophysiology of neuronal diseases [5–7]. Alternatively, it has
been reported that direct differentiation into neurons from hPSCs can be achieved by overexpressing
Neurogenin2 (Ngn2), a bHLH-type proneural factor [8]. By manipulating Ngn2 expression with a
tet-inducible expression system, all cells that have survived drug selection could be induced into
excitable neurons in a doxycycline-dependent manner. As 100% differentiation/induction can be
achieved in principle using this method, variability of induction efficiency between experimental
batches and clones will be reduced, resulting in much higher credibility of biochemical analyses [9,10].
Although this neural cell purification technique is very useful, the extensive time required for neuronal
maturation remains an issue. Thus, the use of various medium compositions and co-culture with
astrocytes has been previously tested to promote neuronal maturation [11,12].
In this study, we aimed to manipulate transient gene expression and develop a method that
can accelerate functional maturity while maintaining high purity induction of neurons with Ngn2
expression. Here, we focused on microRNA-9/9* (miR-9/9*) and microRNA-124 (miR-124), which
have been implicated in efficient neuronal differentiation and functional maturity [13,14]. miR-9/9*
and miR-124 function as a molecular switch of chromatin modifiers and antagonize anti-neurogenic
pathways by suppressing USP14, leading to the destabilization of EZH2 and REST, which is then
accompanied by dynamic changes in chromatin structure [15,16]. Specifically, miR-9 and miR-124 have
been shown to suppress BAF53a (a subunit of the BAF chromatin remodeling complex)-induced neural
progenitor proliferation, thereby enhancing the switch to the BAF53b neuron specific subunit, which
strongly promotes neurite outgrowth [16–20]. These miRNAs have attracted attention in recent years
because their overexpression can directly and efficiently transdifferentiate human adult fibroblasts
to neurons [21,22]. Of note, it is assumed that cells are subjected to strong stress when undergoing
intense conversion [23]; however, temporarily inhibiting caspase activity could effectively suppress
programmed cell death. We believe that transiently expressing Bcl-xL, which can suppress cellular
stress associated with cell fate conversion [24], will also be effective when converting iPSC into neurons.
In this study, we show that the combination of the expression of Ngn2 and Bcl-xl-miRNA-9/9*-124 leads
to robust neural differentiation and maturation from pluripotent stem cells. Additionally, we describe
the potential of this method as an efficient and robust system that can be used for screening neuronal
pathophysiology and drug discovery.
2. Materials and Methods
2.1. Undifferentiated hPSC Culture
The hESC line KhES1 [25], the hiPSC lines 1210B2 [26], 201B7 [1], and 414C2 [27] were used as the
healthy control human hPSC lines. The PS1-mutated hiPSC lines PS1-2 and the PS2-mutated hiPSC
lines PS2-1 [24] were used as the FAD iPSC lines. hPSCs were cultured with or without feeder cells.
For on-feeder culture, iPSCs were grown on mitomycin-Ctreated SNL murine fibroblast feeder cells in
standard human pluripotent stem cell medium (DMEM/F12 medium, FUJIFILM Wako Pure Chemical,
Osaka, Japan) containing 20% Knock Out Serum Replacement, KSR (Thermo Fisher Scientific, Waltham,
MA, USA), 0.1 mM nonessential amino acids, 0.1 mM 2-mercaptoethanol (Merck, Darmstadt, Land
Hessen, Germany), and 4 ng/ml fibroblast growth factor 2 (PeproTech) at 37 ◦ C in an atmosphere
containing 3% CO2 . The feeder-free culture was prepared as previously described [26,28] with slight
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modifications. Briefly, hPSCs were maintained in StemFit/AK02N (Ajinomoto, Tokyo, Japan). Cells
were passaged using 0.5× TrypLE select (Thermo Fisher Scientific, Waltham, MA, USA) in PBS(-) every
7 d and seeded at 1.5 × 105 cells/well of tissue culture treated six-well plate in 1.5 or 2.0 mL medium
with 1.5 µg/ml iMatrix-511 silk (Laminin-511 E8, Nippi, Tokyo, Japan) in the presence of 10 µM Y27632
(Nacalai, Kyoto, Japan) for the first day. Culture media were changed on days 1, 3, and 5.
2.2. PiggyBac Vector Transfection
Based on a previous study [9,10,29], Ngn2-inducible iPSCs were established using the following
vectors: PB-TET-PH-lox66FRT-NEUROG2, pCMV-HyPBase-PGK-Puro and PB-CAGrtTA3G-IH. These
vectors were co-transfected into dissociated iPSCs using Gene Juice Transfection Reagent (Merck,
Darmstadt, Land Hessen, Germany). The transfectants were cultured in StemFit/AK02N containing
20 µM Y27632, 450 µg/ml hygromycin (FUJIFILM Wako Pure Chemical, Osaka, Japan) and 2–10 µg/ml
puromycin (Merck, Darmstadt, Land Hessen, Germany) on 3.0 µg/ml iMatrix-511 silk-coated
tissue culture plates. Of the surviving cells, only the clones capable of neuronal induction in a
Dox-dependent manner while maintaining undifferentiated properties in hPSC medium were expanded
and cryopreserved for this study.
2.3. Preparation and Infection of Lentiviruses
Lentiviruses were purchased from VectorBuilder (Chicago, IL, USA) or produced in HEK293T
cells via the transient transfection of three plasmids: the packaging construct pCAG-HIVgp, VSV-G
and Rev-expressing construct pCMV-VSV-G-RSV-Rev, and self-inactivating (SIN) lentiviral vector
construct (CSIV-124-9-BclxL-TRE-EF-KT, CSIV-124-9-BclxL-TRE-EF-BsdT, pLV-Puro-TRE3G-BclxL,
pLV-Puro-TRE3G-Pri-miR-9-3, pLV-Puro-TRE3G-Pri-miR-124a-2, pLV-Puro-TRE3G-Pri-miR-9-3-Pri
-miR-124a-2, pLV-Puro-TRE3G-BclxL-Pri-miR-9-3-Pri-miR-124a-2 and pLV-SYN1-jGCaMP7s-P2A
-NLS-mCherry). As the original tet-inducible BclxL and miR-9/9*-124 lentiviral vector, pTight-9/
9*-124-BclxL [24], was a second-generation lentiviral vector, we transferred the expression cassette
into a third-generation self-inactivating lentiviral vector backbone. The tet-inducible all-in-one
self-inactivation lentiviral vector expressing BclxL and miR-9/9*-124, CSIV-124-9/9*-BclxL-TRE-EF-KT,
was constructed by a Multisite Gateway-based method as previously described [30]. The human
BclxL gene or the miR-9/9*-124 was amplified by PCR by using a primer set with corresponding
additional attB-signals at 5’-ends and pTight-9/9*-124-BclxL as a common template. The resultant
attB-signal flanked PCR fragment, B3-hBclxL-B2 or B2r-miR-9/9*-124-B4 was cloned into pDONR-P3P2
or pDONR-P2rP4 [30], respectively, by Gateway BP cloning. The resultant entry clones, pENTR-B3hBclxL-B2 and pENTR-B2r-miR-9/9*-124-B4, were assembled into a tet-inducible Multisite Gatewaycompatible self-inactivation lentiviral vector, CSIV-DEST-R4R3-TRE-EF-KT, by Gateway LR cloning.
CSIV-DEST-R4R3-TRE-EF-KT was a derivative of a tet-inducible Gateway-compatible self-inactivation
lentiviral vector, CSIV-RfA-TRE-EF-KT [31], the attR1 and attR2 signals of which were converted into
attR3 and attR4 signals, respectively, for enabling Multisite Gateway LR cloning by BP reaction with a
modified conversion vector [32]. The conversion vector, pENTR-L1-R3-TetR-ccdB-R4-L2, was modified
from the original pDONR-R3-R4 vector, in order to obtain a tetracycline-resistance gene instead of
a chloramphenicol-resistance gene to facilitate selection of the converted Multisite Gateway vector.
A slightly modified vector, CSIV-124-9/9*-BclxL-TRE-EF-BsdT, in which a humanized monomeric
Kusabira-Orange 1 (mKO1) fluorescent protein gene [33] is replaced by the blasticidin-resistance gene,
was also constructed by replacing the GFP expression cassette of CSIV-GFP-TRE-EF-BsdT with the
expression cassette of CSIV-124-9/9*-BclxL-TRE-EF-KT.
For generating lentiviral vectors, on day 0, HEK293T cells were passaged in Poly-ornithine-coated
dishes in DMEM containing 10% FBS and cultured at 37 ◦ C and 5% CO2 for 24 h. The transfection of
each gene and packaging and coat proteins were performed using polyethylenimine (PEI). For each
dish, a cocktail of SIN, pCAG-HIVgp, pCMV-VSV-G-RSV-Rev, and PEI was suspended in Opti-MEM
(Thermo Fisher Scientific, Waltham, MA, USA). Subsequently, the DNA/PEI mixture was added to the
cells and after 12 h, the supernatant was changed to DMEM with 3% FBS containing 10 µM forskolin
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to enhance virus production. After 48 h, the supernatant was collected and filtered through a 0.45 µm
filter (Millipore, Burlington, MA, USA). Lentiviruses were resuspended with Opti-MEM or PBS (-) and
frozen at −80 ◦ C until further analysis. For infection, lentiviral solutions were added to hPSCs with
MOI = 2.0, followed by incubation for 48 h, after which the total hPSCs medium was changed with
fresh medium.
2.4. Neuronal Differentiation by Transient Expression of Ngn2 and/or microRNAs from hPSCs
Feeder-free cultured hPSCs were used for the induction of neuronal differentiation. The cells
were dissociated using 0.5× TrypLE Select and seeded on culture dishes coated with poly-L-lysine,
and iMatrix-511. To induce glutamatergic neurons, Ngn2-transduced cells were cultured in neuronal
medium with the following composition: Neurobasal Plus medium containing 2% B27 Plus supplement,
1% Culture One supplement, 1% Glutamax (Thermo Fisher Scientific, Waltham, MA, USA), 200 µM
L-ascorbic acid (Merk, Darmstadt, Land Hessen, Germany), 100 µM dbcAMP (Nacalai, Kyoto, Japan),
20 ng/ml BDNF, 20 ng/ml GDNF, 20 ng/ml NT-3 (Alomone labs, Jerusalem, Israel) and 0.5 µg/mL
iMatrix-511 silk. 20 µM Y27632 and 2 µg/ml Dox (FUJIFILM Wako Pure Chemical, Osaka, Japan) were
added on day 0. On day 5, the medium was replaced with the fresh neuronal medium described above.
For the CellROX assay and extracellular flux analyses assay, cells were maintained in the following
medium after day 5: Neurobasal plus medium containing 2% B27 minus antioxidants, 1% Culture One
supplement, 1% Glutamax, 20 ng/ml BDNF, 20 ng/ml GDNF, 200 µM L-ascorbic acid, 300 µM dbcAMP
and 0.5 µg/ml iMatrix-511 silk. The medium was replaced every 3 days after day 5.
2.5. Neuronal Differentiation Using Dual SMAD Inhibition from hPSCs
We modified the protocol for neuronal induction shown in [7]. Briefly, for preparing dual SMAD
inhibitor-treated hPSCs, cells were cultured in Stem Fit/AK02N containing 1 µM SB431542 (Merck,
Darmstadt, Land Hessen, Germany), 1 µM Dorsomorphin (Santa Cruz Biotechnology, Dallas, TX, USA)
and 1 µg/ml Y27632 from day 1 to 7. On day 7, cells were dissociated into single cells using TrypLE
Select and cultured in KBM Neural Stem Cell (KOHJIN BIO, Sakado, Saitama, Japan) containing B27
supplement with 2 µM SB431542, 2 µM IWP-2 (Merck, Darmstadt, Land Hessen, Germany) and 10 µM
Y27632 at 4% O2 /5% CO2 . On day 14, cells were dissociated again, followed by culture in the same
conditions as day 7. On day 20, cells were dissociated into single cells using TrypLE Select and plated
on culture plates coated with Matrigel (Corning, Steuben County, NY, USA) and cultured in a neuronal
medium (Neurobasal plus medium containing 2% B27 plus supplement, 1% Culture One supplement,
1% Glutamax, 200 µM L-ascorbic acid, 300 µM dbcAMP, 20 ng/ml BDNF, 20 ng/ml GDNF, 20 ng/ml
NT-3 and 0.5 µg/ml iMatrix-511) at the normal (20%) O2 concentration/5% CO2 . The medium was
replaced every 3 days.
2.6. RNA Extraction and Quantitative Reverse-Transcription PCR
RNA was extracted from the cells using the microRNeasy mini Kit (Qiagen, Hilden, North
Rhine-Westphalia, Germany). One hundred nanograms of RNA was used to prepare cDNA using
the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA). qRT-PCR was performed with SYBR
Premix ExTaqII (TaKaRa Bio, Kusatsu, Shiga, Japan) using the ViiA 7 real-time PCR system (Thermo
Fisher Scientific, Waltham, MA, USA). Values were normalized to ActB levels. The comparative (∆∆Ct)
method was used to analyze the data. See the sequences of primers used for qRT-PCR in Supplemental
Table S1.
2.7. Immunofluorescence Analysis
Cells were fixed with 4% paraformaldehyde for 20 min at room temperature and then incubated
with blocking buffer (PBS(-) containing 2% NGS, 2% BSA, and 0.2% Triton X-100) for 1 h at room
temperature. Then, the cells were incubated overnight at 4◦ C with primary antibodies (see Supplemental
Table S2), which were diluted in blocking buffer without Triton X-100. The cells were washed three
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times with PBS and then incubated with secondary antibodies Alexa Fluor 488, Alexa Fluor 555,
or Alexa Fluor 647 (1:1000; Thermo Fisher Scientific, Waltham, MA, USA) and 10 µg/ml Hoechst
33342 (Merck, Darmstadt, Land Hessen, Germany) for 1h at room temperature. After washing with
PBS, the cells were examined with a BZ-9000 microscope (Keyence, Osaka, Japan), IN Cell Analyzer
6000 (GE Healthcare, Chicago, IL, USA) and LSM700 (Zeiss, Oberkochen, Land Baden-Württemberg,
Germany). The primary antibodies used in this study are listed in Supplemental Table S2.
2.8. High-Content Image Analysis
For cell population assays, stained plates were imaged with an IN Cell Analyzer 6000; a set of
5 × 5 fields was collected from each well using the 20× objective lens. For quantitative analysis of the
synaptic area, stained plates were also imaged with an IN Cell Analyzer 6000; a set of 6 × 6 fields was
collected from each well using the 60× objective lens. Analysis was performed using IN Cell Developer
Toolbox version 1.9 (GE Healthcare, Chicago, IL, USA). Intact nuclei stained by the Hoechst dye were
identified and those that were >50 µm2 in surface area and with intensity levels that were typical
and lower than the threshold brightness of pyknotic cells were defined as traced nuclei. Each traced
nuclear region was then expanded by 50%. Using the expanded nuclear region images, neuronal
markers (Tubb3, MAP2, and NeuN) were identified and the percentage of each marker was calculated
from these images. Using these traced neuronal images of each cell, neurite length was analyzed.
Synaptic areas were defined by binarized images of Synapsin I or PSD95, which overlapped with the
Tubb3-stained area.
2.9. Calcium Imaging
hPSCs were infected with jGCaMP7s lentivirus (MOI = 2) 6 days before neuronal induction for
calcium imaging. Calcium imaging analyses were performed on day 20 after neuronal induction on
a glass-bottom 96-well multi plate (Eppendorf, Hamburg, Germany). Half of the culture medium
was replaced, following 10 µg/ml Hoechst treatment 24 h before imaging. Changes in fluorescence
intensity were measured using an IX83 inverted microscope (Olympus, Tokyo, Japan) equipped with
an Electron Multiplying CCD Camera (Hamamatsu Photonics, Hamamatsu, Shizuoka, Japan) and
LED illumination system pE-4000 (CoolLED, Andover SP10 5NY, UK). We recorded 5000 frames
(1 frame: 31–32 ms) per well using the stream acquisition mode. MetaMorph Image Analysis Software
(Molecular Devices, San Jose, CA, USA) was used to analyze the live cell calcium traces. Regions of
interests (ROIs) were set only for mCherry-positive neurons. ROIs were drawn on cells based on time
projection images of the recordings. ROI traces of the time course of changes in fluorescence intensity
were generated and used as substrates for subsequent analyses. To adjust for photobleaching, the
difference in intensity between the first and last frames was calculated and subtracted from the raw
intensity. The change in fluorescence intensity over time was normalized as ∆F/F= (F-F0)/F0, where F0
is fluorescence at the starting point of exposure (time 0). ∆Fmax was defined as the difference of the
largest change in ∆F/F.
2.10. Multiple/Microelectrode Array (MEA) Analysis
MEA was assayed using the Maestro system (Axion Biosystems, Atlanta, GA, USA). Neuronal
inductions from hPSCs were performed in 48-well MEA plates coated with polyethylene imine and
50× Matrigel (Corning). A total 1.5 × 105 cells in 30 µl culture medium were seeded in an electrode
well. Thirty minutes after seeding, 470 µl of culture medium was added. For neuronal differentiation,
hPSCs were cultured in induction medium for the first 5 days and then in maintenance medium
until day 35. Data were acquired using a sampling rate of 12.5 kHz and filtered using a 200–3000 Hz
Butterworth bandpass filter. The detection threshold was set to +6.0 × SD of the baseline electrode
noise. Five minutes of activity were subsequently recorded at 37 ◦ C. Given the considerable variation
in spike count between wells and plates, we focused on active electrodes (electrodes with an average of
>5 spikes/min), which were certain to make contact with neurons. The number of active electrodes and
the mean spike rate per active electrode (spikes per second) was calculated using the spike count file
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generated by the Axion Integrated Studio program (Axion Biosystems, Atlanta, GA, USA). The spike
raster plots were generated using the Neural Metric Tool (Axion Biosystems, Atlanta, GA, USA). Single
electrode bursts were defined as the count number of >5 spikes/100 ms. Network bursts were defined
as the count number of >50 spikes/100 ms occurring simultaneously in 35% of the electrodes.
2.11. ELISA for Aβs
iPSCs were seeded at a density of 1.0 × 105 cells/well in a 48-well plate and cultured in neuronal
medium with 2 µg/ml Dox and 2 µg/ml Y27632 at 37 ◦ C in 5% CO2 . Five days after seeding the
cells, the medium was replaced with fresh neuronal medium, and cells were cultured until day 20
or day 40. The culture medium was fully changed with 500 µl/well of fresh medium 72 h before the
harvest. The culture supernatant was centrifuged at 200× g to remove insoluble material and the
supernatants were collected and stored at −80 ◦ C. The remaining neuronal cells were lysed in RIPA
buffer (Santa Cruz Biotechnology, Dallas, TX, USA), and the protein concentration was measured
by BCA Protein assay (Thermo Fisher Scientific, Waltham, MA, USA). Aβ40 and Aβ42 levels in the
conditioned medium were measured using the Human β Amyloid (1–40) ELISA Kit II (FUJIFILM Wako
Pure Chemical, #298–64601, Osaka, Japan) and Human β Amyloid (1–42) ELISA Kit High Sensitive
(FUJIFILM Wako Pure Chemical, #296–64401, Osaka, Japan), according to the manufacturer’s protocol.
The concentration of each Aβ species was normalized by the protein levels in the culture.
2.12. Determination of OCRs
Mitochondrial OCRs in cell cultures were measured using an XFe24 Extracellular Flux Analyzer
(Agilent Technologies, Santa Clara CA, USA). The iPSCs were seeded at a density of 5 × 104 cells/well
in a XFe24-well cell culture microplate (Agilent Technologies, Santa Clara CA, USA) and cultured in
neuronal medium with doxycycline at 37 ◦ C in a 5% CO2 atmosphere. Five days after seeding the cells,
the medium was replaced with culture medium without doxycycline, and the cells were cultured for 7
or 15 days. The medium was replaced with XF DMEM medium (Agilent Technologies, Santa Clara CA,
USA) containing 10 mM glucose, 1 mM sodium pyruvate, and 2 mM L-glutamine, and the plates were
pre-incubated in a CO2 -free incubator at 37 ◦ C for 1 hour for equilibration and thereafter processed in
the XF analyzer for OCR analysis. OCRs were recorded three times, followed by sequential injections of
1 µM oligomycin, 0.5 µM FCCP, and 0.5 µM antimycin A and rotenone into each well. The basal OCR
was calculated by subtracting the OCR values obtained after the addition of rotenone and antimycin
A from the OCR values of the third measurement of the experiment. The spare respiratory capacity
was calculated using the ratio of maximal OCR, which was calculated by subtracting the OCR values
obtained after the addition of rotenone and antimycin A from the OCR values obtained after the
addition of FCCP, against basal OCR. As it is difficult to perform the assay in many clones, we selected
one clone each for 414C2, 1210B2, PS1-2 and PS2-1 to effectively perform the assay. After the analysis,
cells were fixed with 4% paraformaldehyde for 20 min at room temperature and stained with 10 µg/ml
Hoechst (Ho). Data were normalized by the number of Ho-positive cells.
2.13. Analysis of Antioxidant Activities
Oxidant levels in neurons were estimated using CellROX Green (Thermo Fisher Scientific, Waltham,
MA, USA), a fluorogenic probe for measuring oxidative stress in live cells. Neurons were incubated
with 5 µM CellROX for 30 min at 37 ◦ C in the dark and washed once with PBS. Cells were fixed with
4% PFA and subjected to immunocytochemical analyses using the anti-Tubb3 antibody. Tubb3+ cells or
Tubb3+/CellROX+ cells were counted using IN Cell Analyzer 6000. Percentages of CellROX+ neurons
were defined as the number of Tubb3+/CellROX+ cells divided by the number of Tubb3+ cells.
2.14. Statistics
Statistical analyses were performed by Dunnett’s or Tukey’s test for multiple comparison,
or Student’s t-test for single comparison. Probability values (p value) < 0.05 were considered to be
statistically significant.
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3. Results
3.1. Acquisition of Neural Differentiation Ability by Overexpression of miRNA-9/9 * and miR-124 for hPSCs
Among various PSC culture methods, we decided to use StemFit/AK02N (Ajinomoto) as the culture
medium, since PSCs rapidly grow in this medium from a single cell level, and Laminin511 E8 fragment
(iMatrix-511, Nippi) as the adhesion substrate [26,28]. The Neurobasal B27 Plus system was used as
a medium for differentiation and maintenance of the neuronal cells (Figure 1A). We first examined
whether miR-9/9*-124 have intrinsically positive effects on neuronal differentiation. The lentiviral
vector used here consists of a sequence in which miR-9/9* and miR-124 are both linked downstream
of the Bcl-xL gene and are driven by the TetO promotor (named BmiRs hereonafter). Furthermore,
mKO1, a fluorescent protein, and rtTA were placed in the opposite direction (Figure 1B). First, KhES1,
a human ES cell line [25], was maintained and cultured in a feeder-free PSCs culture system [28].
One day after the passage, the lentivirus was infected at MOI = 2, and 2 days later, the medium was
replaced to withdraw the virus. On day 7, PSCs were dissociated into single cells and replated in
neuronal medium containing Dox. Expression of mKO1 in the cells indicated successful infection of the
lentivirus. Fourteen or twenty days after the induction, many, but not all, BmiRs (Dox+) cells showed
Tubb3-positive neurite-like structures, while both non-infected cells and BmiRs (Dox-) cells did not
show a neuron-like morphology despite the presence of the neuronal medium. Compared to the BmiRs
(Dox-) cells group, the BmiRs (Dox+) cells group seemed to have accumulated mKO1 protein, probably
because it entered the post-mitotic phase, and exhibited a rather strong fluorescent signal (Figure 1C,D,
Figure S1). Cells were harvested and examined for neuronal gene and pluripotency-marker expressions.
In the miRNA-driven group, the expression levels of neuronal marker genes were increased, while
the expression of Pou5f1 decreased compared with the non-driven group. The expression of Gfap,
an astrocyte marker, was slightly increased by the effect of the neuronal medium but was not changed
drastically by BmiRs expression (Figure 1E). In summary, we demonstrated that the transient expression
of BmiRs in a single-cell feeder-free culture system promoted differentiation into neuron-like cells,
although these cells did not necessarily adopt neurite morphology. Thus, we speculated that the effects
of BmiRs alone on neuronal induction might be limited.
3.2. Effect of BmiRs Addition on Neural Induction Using Ngn2
Next, we examined the effect of adding BmiRs for neuronal induction when using the PiggyBac
vector-based Tet-On-Ngn2 gene expression system, which we had already established in previous
studies [9,10]. Several types of pluripotent stem cell lines from various origins generated using multiple
reprogramming methods were prepared to confirm that the results did not change despite the different
background. We used KhES1 [25], a human ES cell line, 201B7 [1], which was established from human
dermal fibroblasts by retroviral infection, 414C2 [27], which was established by episomal plasmids
from a donor related to that of 201B7, and 1210B2 [26], which was established using episomal plasmids
from peripheral blood mononuclear cells (Figure 2A). First, Tet-On-Ngn2 was introduced by the
PiggyBac transposon (as seen in Figure 2D), and subsequently, drug selection was performed and
hPSCs with high neuronal differentiation efficiency were subcloned (Figure 2B). Then, the lentivirus
for miR-9/9*-124 expression (as seen in Figure 2E) was infected in the same manner as described above,
and further drug selection was performed to obtain cells transfected with TetO-BmiRs and TetO-Ngn2.
In this state, maintenance, growth, and cryopreservation of the cells were possible. Then, after single
cell dissociation, differentiation was induced by Dox and the neuronal medium (Figure 2C). As a result,
as in the case of the induction using Ngn2 alone, all of the stem cell lines exhibited extremely high
efficiency of neural differentiation and uniform-looking neurons appeared as of day 20 (Figure 2F).
In the BmiRs expression group, it was difficult to determine the neural differentiation efficiency with
only brightfield imaging (Figure 2E, Figure S2A). Thus, we performed immunocytochemistry with
neuronal markers. The Tubb3+ cell rate did not significantly change between the BmiRs- and BmiRs+
groups, while the MAP2+ and NeuN+ cell rates, which indicate neuronal maturation, were significantly
higher in the BmiRs+ group than in the BmiRs- group (Figure 2G,H). Moreover, Ki67+ proliferating
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3.3. Alteration of Marker Gene Expression Levels by the Combination of Ngn2 and BmiRs
Our results suggested that the addition of BmiRs has a positive effect on neural differentiation.
Thus, quantitative PCR was performed to verify whether there were changes in specific functional
properties (Figure 3). The four pluripotent stem cell lines described above were used for this experiment.
For each strain, we prepared neural stem cells (NSCs) in the form of neurospheres on day 20 and
terminally differentiated neurons 20 days after adhesion (i.e., 40 days in total) (as seen in Figure S3A,B),
both of which were obtained using the dual SMAD inhibition method, and day 20 and 40 cells obtained
by Ngn2
induction
Cells 2020,
9, 532 with or without BmiRs (Figure S3C).
13 of 28
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3.4. Higher Neuronal Function Acquired with the Addition of Ngn2 + BmiRs
Studies on cell morphology and marker gene expression have shown that the combination of
Ngn2 + BmiRs may promote rapid neural differentiation and maturation. To evaluate whether the
neurons were functionally mature, we examined their calcium activity. To measure calcium
concentration in a neuron-specific and highly sensitive manner, jGCaMP7s [25], expressed
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PSC markers were apparently lower in the “Ngn2+BmiRs-(Day20)” group than in the “PSCs”
group. The addition of BmiRs or long-term culture changed the PSC expression levels. NSC/NPC
marker expression was lower in the “Ngn2+BmiRs- (Day20)” group compared to the NSC-derived
neurons and the “BmiRs+” group showed a similar tendency. Interestingly, Pax6 tended to rise when
BmiRs were added during the early culture period. It remains unclear whether this was due to the
function of miRs or Bcl-xL. Neuronal gene expression in the “Ngn2+BmiRs- (Day20)” group tended
to be comparable or slightly lower than that in the NSC-derived neurons. This may be because
NSC-derived neurons were cultured for a total of 40 days. Conversely, in the “Ngn2+BmiRs+(Day20)”
group, the expression levels of many neuronal genes were increased, particularly the synapse-related
genes SynI (Synapsin I) and Dlg4 (PSD95). Forebrain-related gene expression levels tended to decrease
slightly in the “Ngn2+” groups compared to the NSC-derived neurons, although curiously, their levels
increased in the “BmiRs+” groups. Exceptionally, Foxg1 was reduced in the “BmiRs+” groups, possibly
because miR-9/9*-124 expression might affect the expression period of Foxg1 to some extent during
development. The alterations of ionotropic glutamate and GABA receptor gene expression levels
were similar to those of the neuronal genes mentioned above. These gene expression levels in the
“BmiRs-” groups tended to be lower than in the NSC-derived neurons, while most of them increased
in the “BmiRs+” group. Thus, it is plausible that the addition of BmiRs enabled the generation of
cells that are electrically functional. Regarding the excitatory/inhibitory neuronal markers, excitatory
neuron marker (Slc17a7: VGluT1; Slc17a6: VGluT2) gene expression levels were not significantly
different between the “Ngn2+” groups and the NSC-derived neurons, while the expression of Vgat and
Gad1: Gadd67 were extremely low in the “Ngn2+” groups. For the majority of the data, this tendency
did not significantly change with the addition of BmiRs or long-term culture, but interestingly, Vgat
was transiently upregulated on day 20. Regarding the astrocyte-related gene expression levels, after
the medium of the PSCs were switched from PSC medium to neuronal medium, the glial marker
genes tended to increase somewhat (as seen in Figure 1E). The introduction of Ngn2 expression here
suppressed the expression of glial marker genes (as observed when comparing the “PSCs” group
and “Ngn2-BmiRs- (Day20)” group), and they were especially reduced in the BmiRs+ group. Among
the exogeneous factors, genes that were constantly expressed were higher in both the early and late
stages of differentiation than those in the non-transfected cell groups. Even after adding BmiRs+,
their expressions altered only slightly. β-geo was specifically expressed at the same time with Ngn2
induction and its expression may have temporarily persisted until day 20. However, its expression
level was sufficiently reduced by day 40 after the removal of Dox. In summary, our results indicated
that the addition of BmiRs to Ngn2 enhanced the expression levels of functional genes related to
neuronal differentiation and functional activity.
3.4. Higher Neuronal Function Acquired with the Addition of Ngn2 + BmiRs
Studies on cell morphology and marker gene expression have shown that the combination of Ngn2
+ BmiRs may promote rapid neural differentiation and maturation. To evaluate whether the neurons
were functionally mature, we examined their calcium activity. To measure calcium concentration
in a neuron-specific and highly sensitive manner, jGCaMP7s [25], expressed downstream of a SynI
promoter, were transfected into iPSCs using lentivirus. All GCaMP-expressing cells expressed mCherry
in their nuclei (Figure 4A). First, the percentage of mCherry+ cells in day 20 neurons was calculated.
The percentage was higher in the Ngn2 + BmiRs group, suggesting that this group had a higher rate of
differentiation and maturation (Figure 4B). We decided to only analyze the cells where GCaMP and
mCherry exhibited an intensity exceeding a certain threshold. The results showed that the BmiRs
group clearly showed a strong spontaneous signal oscillation with a larger population of active cells
(Figure 4C–F). Interestingly, the amplitude of the signal was synchronized among different cells in the
same field of view, suggesting the formation of a neural network. Then, to obtain morphological data on
synapse formation, we obtained immunofluorescent images using anti-Synapsin1, a presynaptic marker
and anti-PSD95, a post-synaptic scaffold protein. Confocal microscopy showed that in the Ngn2 +
BmiRs group, the area of Synapsin1 per neurite did not significantly alter, while SynI mRNA expression
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levels were increased in Ngn2+BmiRs (Figure 3). However, the PSD95-positive area was increased
(Figure 4G,H,I). Although we have yet to address why PSD95 alone makes such alteration at the
protein level, it is likely that this has stabilized the synaptic junction as a result. Thus, the synchronous
oscillation of GCaMP fluorescence may have occurred due to synapse formation between the neurons
Cells 2020, 9, 532
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in the Ngn2 + BmiRs group.

Figure4.4.Evaluation
Evaluation of
using
GCaMP
and and
quantification
of synapse-related
Figure
of neuronal
neuronalfunctionality
functionality
using
GCaMP
quantification
of synapse-related
proteins.
(A)
Design
of
the
lentiviral
vector
for
Synapsin1::jGCaMP7s-T2A-NLS
-mCherry.
(B) Ratio
proteins. (A) Design of the lentiviral vector for Synapsin1: jGCaMP7s-T2A-NLS -mCherry.
(B) Ratio of
+ cells in live cells. The number of total cells was defined as
+
of
positive
cells
for
Synapsin1::mCherry
positive cells for Synapsin1: mCherry cells in live cells. The number of total cells was defined as the
the total number of Ho signal. (n = 4 independent experiments; mean ± SEM; *p < 0.05, Dunnett’s test).
(C) Representative GCaMP7s and mCherry images. The circled ROIs are depicted in (D) as timedependent changes in GFP fluorescence intensity. Scale bar: 50 µm. (D) Representative images of
GCaMP spikes and display of parameters (ΔFmax). (E) Comparison of ΔFmax values. The average
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total number of Ho signal. (n = 4 independent experiments; mean ± SEM; * p < 0.05, Dunnett’s
test). (C) Representative GCaMP7s and mCherry images. The circled ROIs are depicted in (D) as
time-dependent changes in GFP fluorescence intensity. Scale bar: 50 µm. (D) Representative images of
GCaMP spikes and display of parameters (∆Fmax). (E) Comparison of ∆Fmax values. The average
value of the control group (BmiRs− ) was used as the reference value. (n = 4 independent experiments;
mean ± SD; *** p < 0.001, Dunnett’s test) (F) Ratio of calcium spike+ cells. The number of cells having a
∆Fmax value of more than 0.01 in (D) was quantified. (n = 4 independent experiments; mean ± SEM;
*** p < 0.001, Dunnett’s test) (G) Representative confocal microscope images of immunocytochemical
analyses of neuronal markers and synaptic markers using confocal microscope (Scale bar: 10 µm).
The enlargement of the area enclosed by the yellow rectangle in the merge photograph are shown on
the right. (H,I) Comparison of SynapsinI+ (H) and PSD95+ (I) area colocalized with Tubb3+ area per
Tubb3+ neurite length. The average value of the control group (BmiRs-) was used as the reference
value. (n = 4 independent experiments; mean ± SEM; * p < 0.05, Dunnett’s test).

3.5. Improvement of Neuronal Activity in Ngn2 + BmiRs Neurons as Indicated by MEA
From the results described above, Ngn2 + BmiRs most likely affected neural network activity;
hence we proceeded in conducting electrophysiological analysis using a micro/multi-electrode array
MEA. Specifically, cells were seeded on a plate in which 16 electrodes were placed per well, and neuronal
differentiation was induced as done in the previous experiments. Measurements were performed over
time until day 35 (Figure S4A). As a result, in the BmiRs+ group, electrodes showing several active
spikes appeared on day 7, and almost all electrodes showed spikes on day 21. Conversely, in the BmiRsgroup, the number of spike-positive electrodes slowly increased over time (Figure 5A). The spike
frequency (MFR) per electrode from which the spikes appeared was also higher for BmiRs+ on day 21
(Figure 5B). Additionally, when the culture progressed, burst firing which involves the continuous
occurrence of spikes were observed (Figure 5F, each line segment is a spike at each electrode, and the
blue label indicates burst firing). The number of bursts and the number of electrodes showing bursts
were also significantly higher in the “BmiRs+” group (Figure 5C,D). Finally, we examined whether
bursts occurred synchronously among the electrodes. Again, BmiRs+ showed significantly higher
network burst frequency, but for khES1 and 414C2, Ngn2 alone also induced relatively high network
bursts. The area surrounded by magenta in Figure 5E,F indicates the timing of the synchronous burst.
This result suggests that in the “BmiRs+” group, neuronal connections were formed within a single
well, while the “BmiRs-” group may have had a partial bias in neuronal communication (Figure S4B).
3.6. Early Expression of Neuronal Phenotypes of Alzheimer’s Disease (AD) in BmiRs-Induced Neurons
Thus far, we showed that the acquisition of early neuronal maturity was made possible by adding
BmiRs during neural induction by Ngn2, which alone was generally thought to result in low neuronal
maturation. Therefore, we considered that this differentiation method might be superior to those
described in previous reports in terms of a pathological evaluation system for neuronal diseases. For
the present study, we decided to examine AD, as it is a highly prevalent disease. Familial AD (FAD) is
most frequently caused by mutations in the genes encoding the γ-secretase-component, one of the
three components of the amyloid precursor protein (APP) processing pathway, which is encoded by
the presenilin-1 (PS1) and presenilin-2 (PS2) genes, or by mutations in the APP gene itself, whereas
a growing consensus suggests that sporadic AD (SAD) is more likely caused by impaired clearance
of Aβ. We have already established iPS cells from patients with mutations in PS1 and PS2 and have
observed a phenotypic expression of high extracellular release of Aβ42 [34,35]. In regard to the method
of this study, we determined that overexpression of Bcl-xL would mask the consequences of the
stress response to cells, which would not be appropriate for the evaluation of disease phenotypes.
Thus, instead of the BmiRs expression used in the previous experiments, we used lentiviral vectors
that do not contain the Bcl-xL gene and can express only miR-9/9* and/or miR-124 (Figure 6A,B). As
the backbone of the miRs expression vector used for this experiment is different from that in the
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previous experiments, we reconfirmed the degree to which miR-9/9*, miR-124, miR-9/9*-124, Bcl-xL,
and Bcl-xL-miR-9/9*-124, which have been inserted into the new vector backbone, would induce neural
differentiation (Figure 6B, Figure S5A). Analysis on day 14 confirmed that neural differentiation can
be performed with high accuracy using any of the vectors when added to Ngn2. Without Ngn2,
miR-9/9* + miR-124 + Bcl-xL showed the greatest neurite extension, followed by miR-9/9* + miR-124,
and then miR-9/9* or miR-124 alone. Bcl-xL alone did not show neurites even in the neuronal medium
(Figure S5B). We then introduced TetO-Ngn2 and TetO-Ngn2 + miRs into the PS1 and PS2 mutant cells
(Figure
S6A).
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3.6. Early Expression of Neuronal Phenotypes of Alzheimer's Disease (AD) in BmiRs-Induced Neurons
Thus far, we showed that the acquisition of early neuronal maturity was made possible by
adding BmiRs during neural induction by Ngn2, which alone was generally thought to result in low
neuronal maturation. Therefore, we considered that this differentiation method might be superior to
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pri-miR-9-3 and pri-miR-124-2 were included in order to induce the expressions of miR-9 and miR-124,
respectively. (C) Secreted Aβ40 and Aβ42 levels in the neuronal cell culture derived from the healthy
control induced-pluripotent stem cells (iPSCs) and the iPSCs with PSEN1 or 2 mutation at day 20
and day 40. (n = 5 independent experiments; mean ± SEM, ## p < 0.01 by Turkey’s test versus CT
(miRs-, Day20); * p < 0.05, Turkey’s test versus the healthy donor group) (D) The ratio of Aβ42/40 (n = 5
independent experiments; mean ± SEM, * p < 0.05, Turkey’s test versus the healthy donor group) (E,F)
Functional analysis of mitochondrial respiration in the neurons at day12. Basal oxygen consumption
rate (OCR), maximal respiration and spare respiration capacity in healthy control and Alzheimer’s
disease (AD) neurons induced by overexpression of Ngn2 with or without miRs in the same neuronal
medium used in the experiments above (E). Total OCR profile along the assay time course is described
in Figure S6B. Spare respiration capacity in a neuronal medium without antioxidant factors are shown in
(F). (n = 5 independent experiments; mean ± SEM; # p < 0.05; ## p < 0.01, Tukey’s test vs. Ngn2 without
miRs, * p < 0.05, ** p < 0.01, *** p < 0.001, Turkey’s test vs. healthy control group) (G) Representative
images of immunocytochemistry for neurons using CellROX, a marker for reactive oxygen species.
Arrowheads indicate CellROX signals. (H) CellROX+ cell population in neurons. (n = 4 independent
experiments; mean ± SEM; * p < 0.05, Turkey’s test vs. healthy control group).

First, as we have done in several previous reports [34,35], we quantified the amount of Aβ40
and Aβ42 in the cell culture supernatant by ELISA. Consequently, on day 20, the amounts of both
Aβ species were increased with the addition of miRs, regardless of whether the cells were healthy or
affected with AD, which was almost equivalent to the amount in the miRs- group on day 40. Moreover,
possibly due to neuronal maturation, the PS1 and PS2 cells of the miRs- groups showed a tendency
of increased Aβ42 levels, which became apparent on day 40. In contrast, the miRs+ group showed
similar amounts and increase of Aβ42 levels on both days 20 and 40. The amount of Aβ42 in the miRs+
group did not rise further beyond day 40 (Figure 6C,D).
In addition, as has been reported for many neurodegenerative diseases, mitochondrial dysfunction
has also been suggested in AD [36–38]. Therefore, we quantified the oxygen consumption rate (OCR)
using an extracellular flux analyzer to investigate energy production by mitochondria in this culture
method. Just as the increase in the amount of Aβ42 in the culture supernatant was confirmed at an
early stage by expression of miRs, phenotypic differences for this experiment was also verified with
the shortest possible culture time. Analysis performed on day 12 revealed that basal respiration and
maximal respiration slightly decreased in the AD group with the expression of miRs. Conversely, there
was no difference between control (CT) and AD groups even with miRs. However, the AD group
resulted in slightly higher spare respiration in the absence of miRs (Figure 6E, Figure S6B). As the
disease phenotype may not be sufficiently recaptured using the current neuronal medium, after day 5,
the cells conditions were changed to use a medium with B27 Supplement whose antioxidant factors
had been removed. As a result, in particular, spare respiration was decreased in the AD miRs+ group
on day 12, while it did not show a significant decrease in the AD miRs- group on day 12. However, they
significantly decreased after day 20 (Figure 6F). These results suggest that mitochondrial dysfunction
in AD cells can be expressed at a very rapid stage by optimizing the induction and culture conditions.
Finally, whether active oxygen accumulates in the cells was examined using CellROX fluorescence.
Results confirmed higher signals in the AD miRs+ group (Figure 6G,H, Figure S6C).
Based on the results above, the addition of miR-9/9* and miR-124 to the Ngn2-induction system is
advantageous for performing phenotypic analysis of AD using iPS cells, as rapid maturation can be
achieved and consequently, disease phenotypes can be easily detected at early timepoints (Figure 7).
This suggests that the induction method in this study is a very useful tool for analyzing neuronal
pathophysiology and for drug screening.
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obtained. On the other hand, the Ngn2 method is insufficient in terms of neuronal maturation. Thus,
expression used in this study, neuronal function can be rapidly enhanced. This enables phenotypic
by adding BmiRs expression used in this study, neuronal function can be rapidly enhanced. This
evaluation, which originally required long-term culture, to be performed within short-term culture.
enables phenotypic evaluation, which originally required long-term culture, to be performed within
short-term culture.
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of Ngn2 greatly enhanced neuronal induction efficiencies [8]. However, functional maturation was
considered to be insufficient, even with this method. To overcome this issue, we proposed a new
induction system for generating mature neurons using the overexpression of Ngn2 with miR-9/9*,
miR-124 and Bcl-xL, which was previously reported as a tool for direct conversion of neurons from
human dermal fibroblasts [21,22]. In this study, using hPSCs of various backgrounds and combining
these two induction techniques (Ngn2+BmiRs), we succeeded in increasing the rate of differentiation
and maturation while maintaining high-purity differentiation into excitatory neurons by overexpression
of Ngn2. It is particularly noteworthy that spontaneous oscillation of intracellular calcium was observed,
and that synaptic protein expression increased and accumulated in neurites. Most likely as a reflection
of these phenomena, early firing spikes, bursts, and even synchronous network bursts were also
detected in the Ngn2+BmiRs using MEA. These results were possibly significant for the analysis of
pathophysiology in neuronal diseases. We used iPSCs from FAD patients [34,35], which were acquired
after the disease phenotypes had become apparent in the patients. Ngn2+miRs promoted extracellular
secretion of Aβ40 and Aβ42 from early stages of culture, resulting in clearly higher Aβ42/40 ratios
in patients with PS1 and PS2 mutations. Furthermore, it was possible to detect abnormalities in
mitochondrion-mediated cellular respiratory levels and active oxygen accumulation at an early stage.
We strongly anticipate that this novel method for neuronal differentiation from PSCs, which enables
early maturation as shown in this study, will be useful for analyses of AD and numerous other types
of neuronal diseases. Interestingly, however, the data in this study also showed unexpected results
and several issues remain to be further examined. For example, Ngn2+BmiRs+ temporarily increased
PSC marker genes expression compared to Ngn2+BmiRs-. In the early differentiation stages, the
undifferentiated cells died easily, although in principle, the Bcl-xL should support survival in the
undifferentiated state. As of present, the details regarding this phenomenon are unknown. As described
above, the NSC marker expression levels were also slightly increased in the Ngn2+BmiRs+. This
may possibly be explained by the presence of a very rare population of BmiRs+ expressing cells with
impaired Ngn2 expression. Although these cells usually die or differentiate into other lineages, they
may have survived because of the Bcl-xL expression and may have forcibly differentiated into NSCs
due to the neural medium.
Because we used Bcl-xL for apoptosis inhibition, it may be possible that cells are actively switching
their energy production pathway to use oxidative phosphorylation [48,49]. In the future, in order
to evaluate the differentiation tendency of the rare populations that existed in our study, it may be
required to verify their gene expression on a single-cell basis.
Previous reports have also suggested that neuronal maturation by miR-9, miR-124, and Bcl-xL
may be due to accelerated differentiation, and that the differentiated cells may reach maturity through
different pathways [50–53]. Thus, there appears to be room for verification regarding what happens
when these factors are continuously expressed for a long period. In this case, excessive miRs expression
may alter the intrinsic homeostasis of neurons [54–56] masking the disease phenotype. Therefore,
disease analysis will need to be carefully performed in consideration of these circumstances.
Further optimization of this current method will deepen our understanding of various neuronal
disorders and help elucidate the fundamental neuronal ability of miRNAs. In this study, we focused
on forebrain diseases, but as shown in [57], by introducing transcription factors that control various
regions and adding compounds [5], a greater variety of neuronal-disease types could be investigated.
In fact, as a method for inducing differentiation into motor neurons, efficient differentiation can be
performed by adding Isl1 and Lhx3 to the BmiRs [15]. Alternatively, introducing Ctip2, Dlx1, Dlx2, and
Myt1l to the BmiRs promotes the generation of striatal medium spiny neurons [58].
iPSCs reprogrammed from various types of cells such as blood cells have already been
established [59–61]. Fortunately, this study demonstrated that iPSCs of various backgrounds can be
successfully differentiated into neurons. In that regard, the original source of cells may not necessarily
need to be PSCs. Direct conversion by expression of transcription factors and miRs was originally
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performed in human fibroblasts [18,21,62,63] and in recent years, a technique for directly converting
neurons from blood cells has also been established [64].
In recent years, brain organoids [65–67] and cell transplantation into animal brains [68] have been
reported as techniques for enhancing functional maturity in the field of brain research using hPSCs.
Compared to these techniques, the high-purity and rapid induction system described in this study has
strengths for biochemical analysis and may enable robust disease phenotyping and drug discovery
using multiple samples. The next step optimization for future medical research will be to simplify the
gene transfer process and minimize the effects of the genomic insertion.
5. Conclusions
In this study, we focused on how to achieve neural maturation from PSCs in vitro. Transient
expression of the Ngn2 gene, which is used as a method for inducing differentiation of pluripotent
stem cells into pure excitable neurons, was insufficient for acquiring neuronal maturation. We used
the miR-9/9*, miR-124, and Bcl-xL genes (BmiRs), which have been used in techniques for direct
conversion of human dermal fibroblasts to neurons. We demonstrated that the addition of BmiRs
to the Ngn2 expression system in PSCs can enhance neuronal maturation of the differentiating cells.
In particular, the generated neurons had increased calcium activity and synapse formation. In addition,
the MEA analyses showed that the electrical network activity was very high. Using this technique,
AD-associated phenotypes could be manifested in a shorter culture period, prompting pathological
analysis of various types of neuronal diseases and the development of therapeutic drugs.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4409/9/3/532/s1,
Figure S1: Brightfield imaging of neuronal morphogenesis resulting from neuronal media or BmiRs overexpression,
Figure S2: Comparison of neuronal differentiation and cell proliferation by combination of Neurogenin2 and BmiRs,
Figure S3: The induction strategies for NSCs-derived neurons and cell culture images used for gene expression
analyses, Figure S4: Representative Raster Plot image drawn by MEA tool software, Figure S5: Induction of
neuronal differentiation by miR9, miR124 or BclxL individually, Figure S6: PS1 and PS2 mutants used in this study
and their in vitro pathological evaluation, Table S1: List of primers (related to Figure 1E, Figure 3), Table S2: List
of antibodies (related to Figure 1D, Figure 2F,G, Figure 4G,H, Figure 6G, Figure S2B, and Figure S6C).
Author Contributions: M.I., S.S., H.W., T.S., H.M., H.U. and H.O. designed the study; M.I., T.A., and S.S.
performed the research; M.I., M.N. and H.O. wrote the paper; H.W., T.S., H.M., S.M. and A.S.Y. contributed
unpublished reagents/analytic tools. All authors have read and agreed to the published version of the manuscript.
Funding: The work was supported by the Research Center Network for Realization Research Centers/Projects of
Regenerative Medicine (the program for Intractable Disease Research Utilizing Disease-specific iPS Cells) from
AMED (grant nos. 17bm0804014h0101, 18bm0804014h0102 and 19bm0804014h0103 to M.I.; 15bm0609003h0004,
16bm0609003h0005, 17bm0609003h0006,17bm0804003h0001, 18bm0804003h0002 and 19bm0804003h0003 to H.O.),
the research Project for Practical Application of Regenerative Medicine from AMED (grant nos. 15bk0104027h003,
16bk0104016h0004, and 17bk0104016h0005 to H.O.), the Japan Society for the Promotion of Science KAKENHI
(grant nos. JP1710083 and JP26830018 to M.I.), the research foundation from Japan Epilepsy Research Foundation
to M.I., and the research foundation from Takeda Science Foundation to M.I. This research was also supported by
internal budgets from Keio University, Osaka University and the National Institute for Basic Biology, including the
Program for the Advancement of Research in Core Projects on Longevity of the Keio University Global Research
Institute from Keio University (to H.O.).
Acknowledgments: We thank Minoru S.H. Ko and Nakatake Yuki (Keio University), and Kosuke Yusa (Wellcome
Trust Sanger Institute) for the materials provided. We would also like to thank Hirofumi Suemori, Shinya
Yamanaka, Keisuke Okita and Makoto Nakagawa (Kyoto University) for kindly providing the following hPSC
lines, KhES1, 201B7, 414C2, and 1210B2, respectively. We also thank Miyuki Chijiiwa (Toyko Medical University)
and all the laboratory members of H.O., especially Sumihiro Maeda, Hiroko Ishii-Shimada and Kent Imaizumi, for
their helpful comments, encouragement and generous support during this study.
Conflicts of Interest: H.O. is a scientific consultant for SanBio, Co. Ltd., and K Pharma Inc. The other authors
declare neither financial nor non-financial competing interests.

Cells 2020, 9, 532

21 of 25

Abbreviations
Aβ
AD
APP
BDNF
BmiRs
BSA
dbcAMP
DMEM
Dox
EBs
ELISA
FAD
FBS
GDNF
hESCs
Ho
hiPSCs
hPSCs
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human embryonic stem cells
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human induced pluripotent stem cells
human pluripotent stem cells
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multiplicity of infection
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pluripotent stem cells
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